about
External adjustment for unmeasured confounders improved drug-outcome association estimates based on health care utilization data.Factors involved in the discontinuation of antihypertensive drug therapy: an analysis from real life data.Are generic and brand-name statins clinically equivalent? Evidence from a real data-base.An ICT and mobile health integrated approach to optimize patients' education on hypertension and its management by physicians: The Patients Optimal Strategy of Treatment(POST) pilot study.Statins and primary liver cancer: a meta-analysis of observational studies.Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure.Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studiesDo patterns of mental healthcare predict treatment failure in young people with schizophrenia? Evidence from an Italian population-based cohort study.Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysisThe impact of the metabolic phenotype on thyroid function in obesity.Proteomic-Biostatistic Integrated Approach for Finding the Underlying Molecular Determinants of Hypertension in Human Plasma.Routine quality care assessment of schizophrenic disorders using information systems.Adherence with antihypertensive drug therapy and the risk of heart failure in clinical practice.Statin use and risk of cataract: A nested case-control study within a healthcare database.Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database.Statins and the risk of diabetes: evidence from a large population-based cohort study.Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?Vascular Dynamics and Peripheral Oxygen Uptake in Obese Individuals during Progressive Physical Exercise.Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis.Intraoperative Retrograde Perfusion Sphincterometry to Evaluate Efficacy of Autologous Vas Deferens 6-Branch Suburethral Sling to Properly Restore Sphincteric Apparatus During Robot-Assisted Radical Prostatectomy.Corrigendum to "Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database" [Diabetes Res. Clin. Pract. 108 (2) (2015) 243-249].Impact of aortic or mitral valve sclerosis and calcification on cardiovascular events and mortality: a meta-analysis.Reply to: "Statins probably do not cause cataracts".Analysis of Predictive Equations for Estimating Resting Energy Expenditure in a Large Cohort of Morbidly Obese PatientsMedication persistence and the use of generic and brand-name blood pressure-lowering agentsPredictors of the transition from metabolically healthy obesity to unhealthy obesityMASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocolHigh-potency statins increase the risk of acute kidney injury: Evidence from a large population-based studySimilarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based studyRoutine quality care assessment of schizophrenic disorders using information systems
P50
Q30571000-574EA8B1-B19B-40AA-A9DB-5EAB5FF39D48Q30824429-16EDBCFF-5BBD-454B-BDAE-82AE0DA4BE65Q30848664-05B794F4-AC56-4458-8D2B-DBA8F209B051Q33453577-A6071CEF-96A5-40AA-9A21-1BD1F074F442Q34301872-BAB37862-1C73-425E-AF2A-99229DE38F41Q34365060-19A31386-32C7-4701-876F-973646042D58Q34537039-C37F9559-360C-42CE-9DE8-1CDC6F4B20D9Q35602162-3C29C7D0-5C3D-4A26-9F90-E2B1A46A7309Q35691666-C8CE0534-F632-4A97-81C7-FA185CC2C92FQ36051510-D3C482B0-D006-47D1-A12F-0F905402E07AQ37199254-8C03CEEF-F542-4616-A60A-DF899A2C1E99Q38707970-C5D7E9B3-E83D-49EA-8D2F-41DC812FF391Q39437386-D5229D4C-2117-41BD-85F9-511F8DD0F7C7Q40682115-72172A16-AF18-4A70-A492-39FC3115400CQ40691564-AD650154-F90A-4315-BBFA-75B49B6E8417Q41274092-2F0C5819-5D25-4840-8AD1-DA7D01403C0CQ43884432-ACB6ACAE-1D78-467C-A53E-7035826F9BA7Q47713064-CD077468-9590-4F98-B4A8-DD8FD5D83A65Q47753827-CB2A6279-8FC0-45A6-A343-74E4E26D7C58Q50036531-615A21E3-AEE1-43A4-9762-B4114A33FB61Q50552614-3D37A4EA-7E75-4483-846B-EA9210CD675BQ53763528-8306B952-2B00-4257-900F-ACBBEDBACDECQ54600149-B3AFD64F-04C6-45DF-B088-897C995E07B7Q54680582-BD969143-3C66-4ECF-8CB8-280CF4D45009Q57174712-7FB78B17-06D8-4F76-B69E-D97D05F44256Q57558943-0A2E146D-6191-436A-979F-8A6ADBD46595Q58102499-72C5A6FD-5AF0-484C-9F86-016C69C14A45Q60946392-CC2AE6E1-C045-4011-BD34-A5233F7F5B41Q62024153-A8FB164B-2185-414F-8B48-19888C2460B5Q87602721-CE8D9FFB-832F-4642-8B48-F7A4C69954EAQ87663317-D4A9C764-40E4-4CD9-97DA-473BD90A8279
P50
description
researcher ORCID ID = 0000-0001-8067-2779
@en
wetenschapper
@nl
name
Davide Soranna
@ast
Davide Soranna
@en
Davide Soranna
@es
Davide Soranna
@nl
type
label
Davide Soranna
@ast
Davide Soranna
@en
Davide Soranna
@es
Davide Soranna
@nl
prefLabel
Davide Soranna
@ast
Davide Soranna
@en
Davide Soranna
@es
Davide Soranna
@nl
P1153
55263515500
P31
P496
0000-0001-8067-2779